NMS·Healthcare·$1.1B·#155 / 520 in Healthcare
AZTA Azenta, Inc.
58SPECULATIVE
CATEGORY BREAKDOWN
GROWTH6
QUALITY46
STABILITY99
VALUATION96
GOVERNANCE38
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+3.6%
6
> 50% strong
Gross Margin
Revenue retained after direct costs
45.5%
63
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
3.0%
98
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.9x
96
< 3x strong
Rule of 40
Growth rate plus operating margin
-0
20
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.9%
7
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-22.2%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE AZTA WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when AZTA's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.